Optimum Investment Advisors Moderna, Inc. Transaction History

Optimum Investment Advisors

$220 Million
Q2 2024

A detailed history of Optimum Investment Advisors transactions in Moderna, Inc. stock. As of the latest transaction made, Optimum Investment Advisors holds 1,384 shares of MRNA stock, worth $84,534. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,384

Previous 1,489 7.05%

Holding current value

$84,534

Previous $158,000 3.8%

% of portfolio

0.07%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$101.21 - $166.61 $10,627 - $17,494	-105 Reduced 7.05%	1,384 $164,000
Q1 2024 Apr 11, 2024	BUY	$85.37 - $115.44 $17,074 - $23,088	200 Added 15.52%	1,489 $158,000
Q4 2023 Jan 08, 2024	SELL	$69.51 - $104.43 $13,902 - $20,886	-200 Reduced 13.43%	1,289 $128,000
Q2 2023 Aug 03, 2023	SELL	$118.5 - $160.53 $24,885 - $33,711	-210 Reduced 12.36%	1,489 $180,000
Q1 2023 May 03, 2023	SELL	$135.66 - $197.02 $44,089 - $64,031	-325 Reduced 16.06%	1,699 $260,000
Q3 2022 Oct 24, 2022	SELL	$118.07 - $194.18 $23,614 - $38,836	-200 Reduced 8.99%	2,024 $239,000
Q2 2022 Jul 12, 2022	SELL	$117.13 - $176.59 $11,713 - $17,659	-100 Reduced 4.3%	2,224 $318,000
Q1 2022 Apr 08, 2022	SELL	$126.46 - $235.05 $12,646 - $23,505	-100 Reduced 4.13%	2,324 $400,000
Q4 2021 Mar 17, 2022	BUY	$225.82 - $368.51 $495,449 - $808,510	2,194 Added 953.91%	2,424 $616,000
Q3 2021 Oct 22, 2021	SELL	$221.9 - $484.47 $37,723 - $82,359	-170 Reduced 42.5%	230 $89,000
Q2 2021 Aug 02, 2021	BUY	$129.91 - $234.98 $6,495 - $11,749	50 Added 14.29%	400 $94,000
Q1 2021 Apr 15, 2021	BUY	$109.18 - $185.98 $38,213 - $65,093	350 New	350 $46,000
Q2 2020 Jul 16, 2020	SELL	$29.67 - $80.0 $11,868 - $32,000	-400 Closed	0 $0
Q1 2020 Apr 21, 2020	BUY	$17.78 - $31.58 $7,112 - $12,632	400 New	400 $12,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $23.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.

Account

Optimum Investment Advisors Moderna, Inc. Transaction History